A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Name: A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Published: 2010
License: Public Domain

Novartis Pharmaceuticals · 2010

ClinicalTrials.gov · Datasets · License: Public Domain · 2010

Open Source ↗

cancer renal-cell-carcinoma

renal cell carcinoma (rcc), cancer, anti-angiogenic agent, renal cell carcinoma, pazopanib, adjuvant therapy, vegfr inhibitor, localized or locally, advanced renal cell carcinoma (rcc) following nephrectomy, advanced rcc, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Related documents